The Melbourne Atherosclerosis Vitamin E Trial (MAVET): A study of high dose vitamin E in smokers

European Journal of Preventive Cardiology

Volumn 13, Issue 3, 2006, Pages 341-347

  Magliano, Dianna ^a   Mcneil, John ^a   Branley, Pauline ^a   Shiel, Louise ^a   Demos, Lisa ^a   Wolfe, Rory ^a   Kotsopoulos, Dimitra ^b   Mcgrath, Barry ^b  

^a MONASH UNIVERSITY   (Australia)

^b DANDENONG HOSPITAL   (Australia)

Author keywords

antioxidant; arterial compliance; carotid medial thickness; oxidant stress; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; PLACEBO;

ADULT; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; CAROTID ARTERY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ATHEROSCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; REGRESSION ANALYSIS; SMOKING; TUNICA INTIMA; VITAMIN E;

EID: 84993746817     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000219108.10167.46     Document Type: Article

References (36)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924.
2. Verlangieri AJ, Bush MJ. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992; 11: 131–138.
3. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003; 107: 947–953.
4. Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, et al. Alphatocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 2002; 106: 1453–1459.
5. Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103: 919–925.
6. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583–1592.
7. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 2004; 24: 1485–1491.
8. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23–33.
9. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001; 357: 89–95.
10. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154–160.
11. Miller ER, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96: 1097–1101.
12. Miwa K, Fujita M, Miyagi Y, Inoue H, Sasayama S. High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm. Clin Cardiol 1995; 18: 267–272.
13. Panzetta O, Cominacini L, Garbin U, Fratta Pasini A, Gammaro L, Bianco F, et al. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol 1995 44: 303–309.
14. Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol 2003; 41: 1205–1210.
15. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002; 359: 1108–1113.
16. Boaz M, Green M, Fainauru M, Smetana S. Oxidative stress and cardiovascular disease in hemodialysis. Clin Nephrol 2001; 55: 93–100.
17. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213–1218.
18. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338–1347.
19. McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscler Thromb Vasc Biol 1998; 18: 1149–1156.
20. Gamble G, Beaumont B, Smith H, Zorn J, Sanders G, Merrilees M, et al. B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. Atherosclerosis 1993; 102: 163–173.
21. Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, et al. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991; 338: 270–273.
22. Liu Z, Brin KP, Yin FC. Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol Heart Circ Physiol 1986; 251: H588–H600.
23. Liang YL, Teede H, Kotsopoulos D, Shiel L, Cameron JD, Dart AM, et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci (Lond) 1998; 95: 669–679.
24. McDowell IF, McEneny J, Trimble ER. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Annu Clin Biochem 1995; 32: 167–174.
25. Salonen JT, Salonen R. Association of serum low density lipoprotein cholesterol, smoking and hypertension with different manifestations of atherosclerosis. Int J Epidemiol 1990; 19: 911–917.
26. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health 1993; 14: 43–68.
27. Little RJ, Rubin DB. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annu Rev Public Health 2000; 21: 121–145.
28. Kenward MG, Molenberghs G. Parametric models for incomplete continuous and categorical longitudinal data. Stat Methods Med Res 1999; 8: 51–83.
29. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447–455.
30. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials [comment]. Lancet 2003; 361: 2017–2023.
31. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004; 164: 1552–1556.
32. Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 2004; 19: 380–389.
33. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90: 440–446.
34. Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998; 158: 668–675.
35. Weinberg RB, VanderWerken BS, Anderson RA, Stegner JE, Thomas MJ. Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol 2001; 21: 1029–1033.
36. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37–46.